| Literature DB >> 32953855 |
Marija Santini1, Ivana Zupetic2, Klaudija Viskovic3, Juraj Krznaric4, Marko Kutlesa4, Vladimir Krajinovic4, Vlatka Lovrakovic Polak5, Vladimir Savic6, Irena Tabain7, Ljubo Barbic8, Maja Bogdanic7, Vladimir Stevanovic8, Anna Mrzljak9, Tatjana Vilibic-Cavlek7.
Abstract
BACKGROUND: Data regarding the neuroradiology features of the West Nile virus neuroinvasive disease (WNV NID) is rather scarce. To contribute to the knowledge of the WNV NID, we present a patient with a combination of encephalitis and acute flaccid paresis, with cauda equina arachnoiditis as the main magnetic resonance (MR) finding. CASEEntities:
Keywords: Case report; Cauda equina; Central nervous system infection; Magnetic resonance; Neuroinvasive disease; West Nile virus
Year: 2020 PMID: 32953855 PMCID: PMC7479571 DOI: 10.12998/wjcc.v8.i17.3797
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Laboratory results in a patient with West Nile virus neuroinvasive disease and cauda equina arachnoiditis
| Cerebrospinal fluid examination | |||
| Cell count/mm3 | 99 | 90 | 0-5 |
| Mononuclear cells (%) | 80 | 96 | Mononuclear 100% |
| Proteins (g/L) | 1.143 | 1.0 | 0.17–0.37 |
| Glucose (% of blood glucose) | 32% | 52% | 60%-70% |
| Blood examination | |||
| C-reactive protein (mg/L) | 0.2 | 7.3 | < 5.0 |
| White blood cells (× 109/L) | 9.1 | 9.7 | 4.0–10.0 |
| Platelets (× 109/L) | 156 | 150 | 100-400 |
| Red blood cells (× 1012/L) | 4.73 | 5.59 | 4.4-5.8 |
| Hemoglobin (g/L) | 128 | 149 | 120–180 |
| Bilirubin (μmol/L) | - | 20 | 3.0–20.0 |
| Aspartate-aminotransferase (U/L) | 37 | 32 | 11–38 |
| Alanine-aminotransferase (U/L) | 27 | 31 | 12–48 |
| Gamma-glutamyltransferase (U/L) | - | 77 | 11–55 |
| Lactate dehydrogenase (U/L) | 206 | 234 | < 241 |
First cerebrospinal fluid examination on day 6.
Virology results in a patient with West Nile virus neuroinvasive disease and cauda equina arachnoiditis
| TBEV | 8 | Neg (0.32)/Neg (4.61) | Neg (0.24)/Neg (< 2) | NT | NT | Neg | Neg | Neg |
| WNV | 8 | Pos (4.40)/Pos (29.31) | Pos (4.61)/Pos (44.67) | NT | Low (3%) | Neg | Neg | Neg |
| 15 | Pos (4.18)/Pos (115.23) | |||||||
| 22 | Pos (4.47)/Pos (143.64) | |||||||
| USUV | 8 | NT/Neg (10.95) | NT/Neg (12.04) | NT | NT | Neg | Neg | Neg |
| TOSV | 8 | NT | NT | Neg/Neg | NT | Neg | Neg | Neg |
| TAHV | 8 | NT | NT | NT | NT | Neg | Neg | Neg |
| BHAV | 8 | NT | NT | NT | NT | Neg | Neg | Neg |
ratio < 8 negative, 8-1.1 borderline, > 1.1 positive.
RU/ml < 16 negative, 16-22 borderline, > 22 positive.
avidity index < 40% low, 40-60% borderline, > 60% high. TBEV: Tick-borne encephalitis virus; WNV: West Nile virus; USUV: Usutu virus; TOSV: Toscana virus; TAHV: Tahyna virus; BHAV: Bhanja virus; NT: Not tested; RT-PCR: reverse-transcriptase polymerase chain reaction; ELISA: Enzyme-linked immunosorbent assays; CSF: Cerebrospinal fluid; IFA: Immunofluorescence assay.
Figure 1Lumbosacral magnetic resonance imaging scan with intravenous Gadolinium administration in a patient with West Nile virus encephalitis and acute flaccid paresis. A: Lumbar spine, midsagittal magnetic resonance, contrast-enhanced T1 fat saturation weighted image demonstrated no extrinsic compression, abnormal signal, or enhancement of the lower part of the spinal cord. There was a marked enhancement of the ventral nerve roots of the cauda equina (orange arrows); B: Sagittal contrast-enhanced T1 fat saturation weighted through the region of the cauda equina shows abnormal – prominent enhancement of the nerve roots (orange arrows).